| CLASSIFICATION | Market |
| LEGAL DISPUTES | with FTC resolved: Abbott had been paying Generic version mfr. US$ 4.5 million a month to keep generic version off the market for 16 months after approval of generic for sale |
| MARKETER'S COUNTRY | USA |
| PRODUCER'S COUNTRY | USA |
| SALES VALUE | Non-Generic's sales in 1999: US$ 500 million |
| STATUS | Non-Generic's patent (Abbott) expiring in 2000 |
| UPDATE | 03.00 |
| MARKETING BY | This data is not available for free |
| PRODUCTION BY | This data is not available for free |
| TRADEMARK | Non-Generic version: Hytrin |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |